Congenital Disorder of Glycosylation Type Ik (CDG-Ik): A Defect of Mannosyltransferase 1

74Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study describes the discovery of a new inherited disorder of glycosylation named "CDG-Ik." CDG-Ik (congenital disorder of glycoslyation type Ik) is based on a defect of human mannosyltransferase I (MT-I [MIM 605907]), an enzyme necessary for the elongation of dolichol-linked chitobiose during N-glycan biosynthesis. Mutations in semiconserved regions in the corresponding gene, HMT-1 (yeast homologue, Alg1), in two patients caused drastically reduced enzyme activity, leading to a severe disease with death in early infancy. One patient had a homozygous point mutation (c.773C→T, S258L), whereas the other patient was compound heterozygous for the mutations c.773C→T and c.1025A→C (E342P). Glycosylation and growth of Alg1-deficient PRY56 yeast cells, showing a temperature-sensitive phenotype, could be restored by the human wild-type allele, whereas only slight restoration was observed after transformation with the patients' alleles.

Cite

CITATION STYLE

APA

Kranz, C., Denecke, J., Lehle, L., Sohlbach, K., Jeske, S., Meinhardt, F., … Marquardt, T. (2004). Congenital Disorder of Glycosylation Type Ik (CDG-Ik): A Defect of Mannosyltransferase 1. American Journal of Human Genetics, 74(3), 545–551. https://doi.org/10.1086/382493

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free